Rockwell Medical (RMTI) Tops Q4 EPS by 4c ; Offers Guidance

Rockwell Medical (NASDAQ: RMTI) reported Q4 EPS of $0.04, $0.04 better than the analyst estimate of $0.00. Revenue for the quarter came in at $24.7 million versus the consensus estimate of $24.07 million.

GUIDANCE:

Rockwell Medical sees FY2025 revenue of $65-70 million, versus the consensus of $83.19 million.

For earnings history and earnings-related data on Rockwell Medical (RMTI) click here.

You May Also Be Interested In

• Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
• Femasys Inc. (FEMY) Misses Q2 EPS by 20c
• H.C. Wainwright Reiterates Buy Rating on Tvardi Therapeutics Inc (TVRD)